Baudax Bio, Inc. Sustainability Profile
Baudax Bio, Inc., a biopharmaceutical company headquartered in the United States, focuses on developing innovative therapeutics for patients in need. Founded in 2018, Baudax Bio has quickly established itself in the industry, particularly in the areas of pain management and anaesthesia. The company’s flagship product, Exparel, is a unique liposomal formulation of bupivacaine, designed to provide prolonged analgesia with a single administration. This innovative approach sets Baudax Bio apart in a competitive market, addressing the growing demand for effective pain relief solutions. With a commitment to advancing patient care, Baudax Bio has achieved significant milestones, positioning itself as a key player in the biopharmaceutical landscape. The company continues to explore new avenues for growth, aiming to enhance the quality of life for patients worldwide.
DitchCarbon Score
How does Baudax Bio, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Baudax Bio, Inc.'s score of 23 is lower than 64% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Baudax Bio, Inc.'s reported carbon emissions
Baudax Bio, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Baudax Bio may not have established formal commitments to reduce its carbon footprint or engage in industry-standard climate initiatives at this time. As the company operates within a sector increasingly focused on sustainability, it may benefit from developing clear climate commitments and reduction strategies to align with industry best practices.
How Carbon Intensive is Baudax Bio, Inc.'s Industry?
How Carbon Intensive is Baudax Bio, Inc.'s Location?
Baudax Bio, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Baudax Bio, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
